BioXcel Therapeutics, Inc.
BTAIQ- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720893
No open-market purchases or sales by BioXcel Therapeutics, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $8.69M in total; Oaktree Capital is the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in BioXcel Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +7 vs. Q1 2026
- Shares held
- 6.18M
- +734.8K (+13.5%) vs. Q1 2026
- Total value
- $8.69M
- +$1.41M (+19.4%) vs. Q1 2026
- New holders
- 10
- 12 more added
- Sold out
- 3
- 8 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BTAIQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $8.69M |
| Q1 2026 | 40 | $7.28M |
| Q4 2025 | 41 | $5.66M |
| Q3 2025 | 35 | $6.05M |
| Q2 2025 | 35 | $1.09M |
| Q1 2025 | 31 | $769.7K |
| Q4 2024 | 49 | $3.22M |
| Q3 2024 | 50 | $1.89M |
| Q2 2024 | 74 | $12.5M |
| Q1 2024 | 74 | $26.1M |
| Q4 2023 | 73 | $27.6M |
| Q3 2023 | 86 | $25.8M |
| Q2 2023 | 88 | $117.8M |
| Q1 2023 | 97 | $325.0M |
| Q4 2022 | 84 | $288.9M |
| Q3 2022 | 85 | $140.3M |
| Q2 2022 | 94 | $167.4M |
| Q1 2022 | 96 | $273.9M |
| Q4 2021 | 93 | $283.1M |
| Q3 2021 | 104 | $388.3M |
| Q2 2021 | 109 | $378.6M |
| Q1 2021 | 118 | $475.2M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding BioXcel Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| US Bancorp | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Triumph Capital Management | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2 | $3 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 12 | $17 | 0.00% | −47−79.7% | Reduced |
| SBI Securities Co., Ltd. | 13 | $18 | 0.00% | −1−7.1% | Reduced |
| IFP Advisors, Inc | 13 | $18 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 21 | $30 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 25 | $35 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 45 | $63 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 60 | $85 | 0.00% | 00.0% | Unchanged |
| Washington Trust Advisors, Inc. | 82 | $116 | 0.00% | −78−48.8% | Reduced |
| Parkside Financial Bank & Trust | 112 | $158 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 227 | $320 | 0.00% | −1,491−86.8% | Reduced |
| Silver Grove Financial Group, Inc. | 331 | $468 | 0.00% | −3−0.9% | Reduced |
| Vanguard Global Advisers, LLC | 493 | $695 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 1,331 | $1.88K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1,428 | $2.01K | 0.00% | +1,428 | New |
| Morgan Stanley | 1,671 | $2.36K | 0.00% | −8,917−84.2% | Reduced |
| Citigroup Inc | 2,998 | $4.23K | 0.00% | +2,998 | New |
| Wells Fargo & Company | 4,337 | $6.12K | 0.00% | +18+0.4% | Added |
| Diversify Wealth Management, LLC | 15,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Diversify Advisory Services, LLC | 15,000 | $13.0K | 0.00% | +15,000 | New |
| Two Sigma Securities, LLC | 10,796 | $15.2K | 0.00% | +10,796 | New |
| Advisor Group Holdings, Inc. | 16,214 | $22.9K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 15,967 | $23.0K | 0.00% | +15,967 | New |
| Portfolio Strategies, Inc. | 16,831 | $23.7K | 0.00% | +4,653+38.2% | Added |
| Susquehanna International Group, LLP | 17,200 | $24.3K | 0.00% | +17,200 | New |
| Beacon Pointe Advisors, LLC | 18,837 | $26.6K | 0.00% | −40−0.2% | Reduced |
| StoneX Group Inc. | 20,684 | $29.2K | 0.00% | +20,684 | New |
| Headlands Technologies LLC | 25,556 | $36.0K | 0.00% | +25,556 | New |
| Quadrature Capital Ltd | 38,038 | $53.6K | 0.00% | +38,038 | New |
| HighTower Advisors, LLC | 41,000 | $57.8K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 56,318 | $79.4K | 0.00% | +20,005+55.1% | Added |
| Jones Financial Companies LLLP | 63,139 | $82.7K | 0.00% | −68,650−52.1% | Reduced |
| Wiley Bros.-Aintree Capital, LLC | 83,588 | $117.9K | 0.00% | +2,724+3.4% | Added |
| FMR LLC | 90,300 | $127.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 92,118 | $129.9K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 136,937 | $193.1K | 0.00% | +52,016+61.3% | Added |
| Citadel Advisors LLC | 149,220 | $210.4K | 0.00% | +149,220 | New |
| UBS Group AG | 158,065 | $222.9K | 0.00% | +105,277+199.4% | Added |
| BlackRock, Inc. | 179,433 | $253.0K | 0.00% | +95,151+112.9% | Added |
| Geode Capital Management, LLC | 242,251 | $341.9K | 0.00% | +12,083+5.2% | Added |
| Oaktree Fund Advisors, LLC | 245,585 | $346.3K | 0.60% | +202,672+472.3% | Added |
| Vanguard Capital Management LLC | 919,545 | $1.30M | 0.00% | +712,206+343.5% | Added |
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 1,380,248 | $1.95M | 0.04% | +1,139,060+472.3% | Added |
| Millennium Management LLC | 2,114,710 | $2.98M | 0.00% | +177,950+9.2% | Added |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −1,910,076−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −96,473−100.0% | Sold out |
| Annis Gardner Whiting Capital Advisors, LLC | 0 | $0 | 0.00% | −156−100.0% | Sold out |